A comprehensive HBV array for the detection of HBV mutants and genotype

Clinical Biochemistry

Volumn 44, Issue 14-15, 2011, Pages 1253-1260

  Chan, Kaimin ^a   Yam, Irene ^a   Yuen, John ^a   Yuen, Man Fung ^a   Lai, Ching Lung ^a   Alexander, Graeme J ^b   Chan, Tai Kwong ^a   Chan, Vivian ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

AS APEX; Drug resistant mutations; Genotype; HBV array

Indexed keywords

2 AMINO 9 (1 PHOSPHONOMETHOXYCYCLOPROPYLMETHYL)PURINE BIS(PIVALOYLOXYMETHYL) ESTER; ADEFOVIR; FAMCICLOVIR; FLUORESCEIN; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; SINGLE STRANDED DNA;

ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; DNA TEMPLATE; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VIRUS DETECTION; VIRUS GENE; VIRUS MUTANT;

CARBOCYANINES; DEOXYCYTOSINE NUCLEOTIDES; DRUG RESISTANCE, VIRAL; FOLLOW-UP STUDIES; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIMIT OF DETECTION; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE; SENSITIVITY AND SPECIFICITY; VIRAL ENVELOPE PROTEINS;

EID: 80052926548     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.07.014     Document Type: Article

References (13)

1. Hepatitis B. World Health Organization Fact Sheet 2004. WHO website World Health Organization. http://who.int/inf-fs/en/fact204.html.
2. Lai C.L., Yuen M.F. Chronic hepatitis B - new goals, new treatment. N Engl J Med 2008, 359:2488-2491.
3. Chang T.T., Liaw Y.F., Wu S.S., Schiff E., Han K.H., Lai C.L., et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 2010, 52:886-893.
4. Yuen M.F., Sablon E., Hui C.K., Yuen H.J., Decraemer H., Lai C.L. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology 2001, 34:785-791.
5. Andreone P., Gramenzi A., Cursaro C., Biselli M., Cammà C., Trevisani F., et al. High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance. J Viral Hepat 2004, 11:439-442.
6. Cooreman M.P., Leroux-Roels G., Paulij W.P. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001, 8:237-247.
7. Yuen M.F., Sablon E., Wong D.K.H., Yuan H.-J., Wong B.C.Y., Chan A.O.O., et al. Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation. Clin Infect Dis 2003, 37:593-597.
8. Buti M., Cotrina M., Valdes A., Jardi R., Rodriguez-Frias F., Esteban R. Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?. J Hepatol 2002, 36:445-446.
9. Pastinen T., Raitio M., Lindroos K., Tainola P., Peltonen L., Syvänen A.C. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res 2000, 10:1031-1042.
10. Chan K., Wong M.S., Chan T.K., Chan V. A thalassaemia array for Southeast Asia. Br J Haematol 2004, 124:232-239.
11. Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979, 281:646-650.
12. Chan K., Sasanakul W., Mellars G., Chuansumrit A., Perry D., Lee C.A., et al. Detection of known haemophilia B mutations and carrier testing by microarray. Thromb Haemost 2005, 94:872-878.
13. Chan K., Yam I., Leung K.Y., Tang M., Chan T.K., Chan V. Detection of paternal alleles in maternal plasma for non-invasive prenatal diagnosis of β-thalassemia: a feasibility study in southern Chinese. Eur J Obstet Gynecol Reprod Biol 2010, 150:28-33.